These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 35434937)

  • 1. Hierarchy-Assembled Dual Probiotics System Ameliorates Cholestatic Drug-Induced Liver Injury via Gut-Liver Axis Modulation.
    Chen QW; Li QR; Cao MW; Yan JH; Zhang XZ
    Adv Sci (Weinh); 2022 Jun; 9(17):e2200986. PubMed ID: 35434937
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Probiotic Lactobacillus rhamnosus GG Prevents Liver Fibrosis Through Inhibiting Hepatic Bile Acid Synthesis and Enhancing Bile Acid Excretion in Mice.
    Liu Y; Chen K; Li F; Gu Z; Liu Q; He L; Shao T; Song Q; Zhu F; Zhang L; Jiang M; Zhou Y; Barve S; Zhang X; McClain CJ; Feng W
    Hepatology; 2020 Jun; 71(6):2050-2066. PubMed ID: 31571251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Target profiling analyses of bile acids in the evaluation of hepatoprotective effect of gentiopicroside on ANIT-induced cholestatic liver injury in mice.
    Tang X; Yang Q; Yang F; Gong J; Han H; Yang L; Wang Z
    J Ethnopharmacol; 2016 Dec; 194():63-71. PubMed ID: 27582267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of a mechanistic biokinetic model for hepatic bile acid handling to predict possible cholestatic effects of drugs.
    Notenboom S; Weigand KM; Proost JH; van Lipzig MMH; van de Steeg E; van den Broek PHH; Greupink R; Russel FGM; Groothuis GMM
    Eur J Pharm Sci; 2018 Mar; 115():175-184. PubMed ID: 29309877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibroblast growth factor 21 ameliorates cholestatic liver injury via a hepatic FGFR4-JNK pathway.
    Zhou C; Pan X; Huang L; Wu T; Zhao T; Qi J; Wu J; Mukondiwa AV; Tang Y; Luo Y; Tu Q; Huang Z; Niu J
    Biochim Biophys Acta Mol Basis Dis; 2024 Jan; 1870(1):166870. PubMed ID: 37696161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors for development of cholestatic drug-induced liver injury: inhibition of hepatic basolateral bile acid transporters multidrug resistance-associated proteins 3 and 4.
    Köck K; Ferslew BC; Netterberg I; Yang K; Urban TJ; Swaan PW; Stewart PW; Brouwer KL
    Drug Metab Dispos; 2014 Apr; 42(4):665-74. PubMed ID: 24154606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disruption of BSEP Function in HepaRG Cells Alters Bile Acid Disposition and Is a Susceptive Factor to Drug-Induced Cholestatic Injury.
    Qiu X; Zhang Y; Liu T; Shen H; Xiao Y; Bourner MJ; Pratt JR; Thompson DC; Marathe P; Humphreys WG; Lai Y
    Mol Pharm; 2016 Apr; 13(4):1206-16. PubMed ID: 26910619
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolomics analysis delineates the therapeutic effects of Huangqi decoction and astragalosides on α-naphthylisothiocyanate (ANIT) -induced cholestasis in rats.
    Qiu J; Yan J; Liu W; Liu X; Lin J; Du Z; Qi L; Liu J; Xie G; Liu P; Wang X
    J Ethnopharmacol; 2021 Mar; 268():113658. PubMed ID: 33307056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of an in vitro cholestatic drug-induced liver injury evaluation system using HepG2-hNTCP-C4 cells in sandwich configuration.
    Sakai Y; Okumura H; Iwao T; Watashi K; Ito K; Matsunaga T
    Toxicol In Vitro; 2019 Dec; 61():104619. PubMed ID: 31394163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gardenia jasminoides Ellis polysaccharide ameliorates cholestatic liver injury by alleviating gut microbiota dysbiosis and inhibiting the TLR4/NF-κB signaling pathway.
    Fang S; Wang T; Li Y; Xue H; Zou J; Cai J; Shi R; Wu J; Ma Y
    Int J Biol Macromol; 2022 Apr; 205():23-36. PubMed ID: 35176320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lactobacillus rhamnosus GG ameliorates triptolide-induced liver injury through modulation of the bile acid-FXR axis.
    Hu S; Tang B; Lu C; Wang S; Wu L; Lei Y; Tang L; Zhu H; Wang D; Yang S
    Pharmacol Res; 2024 Jun; ():107275. PubMed ID: 38908615
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gentamicin alleviates cholestatic liver injury by decreasing gut microbiota-associated bile salt hydrolase activity in rats.
    Ma Y; Wang H; Yang J; Xin M; Wu X
    Eur J Pharmacol; 2023 Jul; 951():175790. PubMed ID: 37179041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Picroside II protects against cholestatic liver injury possibly through activation of farnesoid X receptor.
    Li T; Xu L; Zheng R; Wang X; Li L; Ji H; Hu Q
    Phytomedicine; 2020 Mar; 68():153153. PubMed ID: 32018210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Picroside II alleviates liver injury induced by alpha-naphthylisothiocyanate through AMPK-FXR pathway.
    Li T; Zheng R; Xu L; Zhou M; Wang X; Guo Q; Ji H; Li L
    Toxicol Appl Pharmacol; 2020 Dec; 408():115248. PubMed ID: 32976922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Yinchenzhufu decoction protects against alpha-naphthylisothiocyanate-induced acute cholestatic liver injury in mice by ameliorating disordered bile acid homeostasis and inhibiting inflammatory responses.
    Wang GF; Li YY; Shi R; Wang TM; Li YF; Li WK; Zheng M; Fan FB; Zou J; Zan B; Wu JS; Ma YM
    J Ethnopharmacol; 2020 May; 254():112672. PubMed ID: 32084553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Yangonin protects against cholestasis and hepatotoxity via activation of farnesoid X receptor in vivo and in vitro.
    Gao X; Fu T; Wang C; Ning C; Liu K; Liu Z; Sun H; Ma X; Huo X; Yang X; Zou M; Meng Q
    Toxicol Appl Pharmacol; 2018 Jun; 348():105-116. PubMed ID: 29660435
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective activation of nuclear bile acid receptor FXR in the intestine protects mice against cholestasis.
    Modica S; Petruzzelli M; Bellafante E; Murzilli S; Salvatore L; Celli N; Di Tullio G; Palasciano G; Moustafa T; Halilbasic E; Trauner M; Moschetta A
    Gastroenterology; 2012 Feb; 142(2):355-65.e1-4. PubMed ID: 22057115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sweroside ameliorates α-naphthylisothiocyanate-induced cholestatic liver injury in mice by regulating bile acids and suppressing pro-inflammatory responses.
    Yang QL; Yang F; Gong JT; Tang XW; Wang GY; Wang ZT; Yang L
    Acta Pharmacol Sin; 2016 Sep; 37(9):1218-28. PubMed ID: 27498779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cultured bear bile powder ameliorates acute liver injury in cholestatic mice via inhibition of hepatic inflammation and apoptosis.
    Cai J; Wu J; Fang S; Liu S; Wang T; Li Y; Zou J; Shi R; Wang Z; Yang L; Ma Y
    J Ethnopharmacol; 2022 Feb; 284():114829. PubMed ID: 34763041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Colesevelam attenuates cholestatic liver and bile duct injury in
    Fuchs CD; Paumgartner G; Mlitz V; Kunczer V; Halilbasic E; Leditznig N; Wahlström A; Ståhlman M; Thüringer A; Kashofer K; Stojakovic T; Marschall HU; Trauner M
    Gut; 2018 Sep; 67(9):1683-1691. PubMed ID: 29636383
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.